Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02222948 |
|---|---|
| Brief Title: | Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis (EMPIRE) |
| First Submitted : | August 20, 2014 |
| First Submitted that Met QC Criteria : | August 20, 2014 |
| First Posted : | August 22, 2014 (Estimate) |
| Certification/Extension First Submitted : | December 20, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | December 20, 2016 |
| Certification/Extension First Posted : | December 21, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 20, 2016 |
| Last Update Posted : | December 21, 2016 (Estimate) |